Premium
Liver metastases from gastric cancer represent systemic disease in comparison with those from colorectal cancer
Author(s) -
Oguro Seiji,
Imamura Hiroshi,
Yoshimoto Jiro,
Ishizaki Yoichi,
Kawasaki Seiji
Publication year - 2016
Publication title -
journal of hepato‐biliary‐pancreatic sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.63
H-Index - 60
eISSN - 1868-6982
pISSN - 1868-6974
DOI - 10.1002/jhbp.343
Subject(s) - medicine , gclm , hepatectomy , colorectal cancer , cancer , gastroenterology , incidence (geometry) , surgery , resection , biochemistry , chemistry , downregulation and upregulation , physics , optics , gene , gclc
Background The aim of this retrospective study was to clarify the difference in behavior and outcome after initial hepatectomy between gastric cancer liver metastases (GCLM) and colorectal cancer liver metastases (CCLM). Methods Data for patients undergoing curative hepatectomy for liver‐only metastases from colorectal cancer ( n = 193) and gastric cancer ( n = 26) performed at single institution with the same criteria regarding the status of liver metastases were reviewed. Post‐hepatectomy recurrence pattern, re‐resection for recurrence, and three different endpoints were evaluated. Results There was no significant difference between the GCLM and the CCLM in the incidence of recurrence (69% vs. 63%, P = 0.553) and recurrence‐free survival (median, 15.2 months vs. 16.5 months, P = 0.230) following initial hepatectomy for liver metastases. However, the GCLM had a higher frequency of systemic unresectable recurrences than the CCLM. Time to surgical failure (median, 15.2 months vs. 39.7 months, P = 0.006) and overall survival (median, 20.1 months vs. 66.2 months, P < 0.001) were significantly shorter in the GCLM than in the CCLM. Conclusions GCLM shows more systemic and aggressive oncological behavior than CCLM after curative hepatectomy even when metastases are confined only to the liver at the time of initial hepatectomy.